Vialwirebiotech, curated
September 30, 2026, 1:45 PM
September 30, 2026
- 12:40 PM · Pharmaceutical Technology12:40 PMEASD 2026: CagriSema weight loss holds at submaximal doses in REDEFINE-1 analysis — Pharmaceutical Technology
- 12:22 PM · BioPharma Dive12:22 PMBristol Myers trial revisions shake confidence in new class of fibrosis drugs — BioPharma Dive
- 12:18 PM · Pharmaceutical Technology12:18 PMAtossa plans shareholder stake in potential PRV proceeds — Pharmaceutical Technology
- 11:54 AM · BioPharma Dive11:54 AMFDA starts review of Roche’s multiple sclerosis pill — BioPharma Dive
- 11:21 AM · Drug Discovery World11:21 AMBII scales up and supports record-high number of new startups — Drug Discovery World
- 10:19 AM · Drug Discovery World10:19 AMFDA approves obinutuzumab for rare autoimmune disease — Drug Discovery World
- 10:15 AM · STAT News
- 9:26 AM · Pharmaceutical Executive9:26 AM<![CDATA[Novo Reports Real-World Data Showing Weight Loss After Switch to Oral Semaglutide Pill]]> — Pharmaceutical Executive
- 9:00 AM · BioWorld9:00 AMInsilico Medicine nominates ISM-1354 as obesity candidate — BioWorld
- 9:00 AM · BioWorld9:00 AMUTR Therapeutics’ UTRxMYCN M1-14 designated US orphan drug — BioWorld
- 9:00 AM · BioWorld9:00 AMCSPC’s herpes zoster vaccine SYS-6052 gains IND approval — BioWorld
- 7:00 AM · Science (News)7:00 AMMethod to ‘watermark’ AI-designed proteins could deter bioweapons, protect scientific credit — Science (News)
- 6:09 AM · Drug Discovery World6:09 AMGSK to acquire potential asset for multiple myeloma — Drug Discovery World
- 5:52 AM · Pharmaceutical Technology5:52 AMOBIO marks $704m funding milestone for Canadian health tech ventures — Pharmaceutical Technology
- 3:36 AM · Pharmaceutical Technology3:36 AMKyowa Kirin, Knight agree Latin American distribution deal for mogamulizumab — Pharmaceutical Technology
- 3:27 AM · SCMP — Tech3:27 AMHong Kong to expand IP financing sandbox after 7 firms secure cheaper loans — SCMP — Tech
September 29, 2026
- 3:24 PM · Pharmaceutical Technology3:24 PMEASD 2026: Orforglipron shows an efficacy edge over oral semaglutide in T2D — Pharmaceutical Technology
- 1:56 PM · STAT News1:56 PMSTAT+: PhRMA taps Eric Cantor as new CEO — STAT News
- 1:54 PM · STAT News
- 1:00 PM · Pharmaceutical Executive1:00 PM<![CDATA[New U.S. Guidance Lays Out Exemptions for 100% Tariffs: Report ]]> — Pharmaceutical Executive
- 12:24 PM · Drug Discovery World12:24 PMScarlet secures $14m DARPA deal for smart red blood cells — Drug Discovery World
- 12:00 PM · BioWorld12:00 PMOtsuka, Ionis notch phase III win in FUS-ALS — BioWorld
- 12:00 PM · BioWorld12:00 PMBeyond Rasonque: deeper, broader and more durable — BioWorld
- 12:00 PM · BioWorld12:00 PMMerck licenses SPR-2015 from China’s Scibrunch in $2B+ deal — BioWorld
- 12:00 PM · BioWorld12:00 PMNovo adds to obesity pipeline with $2.6B Hengrui deal — BioWorld
- 12:00 PM · BioWorld12:00 PMTolerance Bio expands thymus platform via $560M Tanabe deal — BioWorld
- 12:00 PM · BioWorld12:00 PMItalian newco Aptadir raises €40M seed round for RNA inhibitors — BioWorld
- 12:00 PM · BioWorld12:00 PMSweden’s Egetis wins FDA approval of Emcitate for MCT8 deficiency — BioWorld
- 12:00 PM · BioWorld12:00 PMEarendil’s AI platform lands $1.5B Genentech collaboration — BioWorld
- 10:08 AM · Pharmaceutical Executive10:08 AM<![CDATA[Pharming CEO Fabrice Chouraqui Steps Down Amid Strategic Disagreement with Board]]> — Pharmaceutical Executive
- 9:00 AM · BioWorld9:00 AMCurrus Biologics’ CUR-001 gains IND clearance for solid tumors — BioWorld
- 9:00 AM · BioWorld9:00 AMIregene’s Nouvsight-001 cleared for clinic in US and China — BioWorld
- 9:00 AM · BioWorld
- 9:00 AM · BioPharma Dive9:00 AMai3Bio, built from two biotechs, pursues a different path to an ‘immune reset’ — BioPharma Dive
- 9:00 AM · BioWorld9:00 AMNovo licenses rights to Hengrui’s HRS-1596 — BioWorld
- 8:49 AM · BioPharma Dive8:49 AMAstraZeneca invests $2B in Summit, gaining ‘seat at the table’ for PD-1/VEGF drug push — BioPharma Dive
- 7:05 AM · STAT News
- 6:50 AM · Drug Discovery World6:50 AMMagnitude Biosciences secures £1.3m investment — Drug Discovery World
- 6:32 AM · Pharmaceutical Technology6:32 AMMSD bets $2.13bn on SciBrunch’s KRAS (ON) inhibitor — Pharmaceutical Technology
- 5:00 AM · SCMP — Tech5:00 AMAstraZeneca, Merck, Novo deals boost Chinese biotech as global interest grows — SCMP — Tech
September 28, 2026
- 4:45 PM · STAT News